nodes	percent_of_prediction	percent_of_DWPC	metapath
Polythiazide—Hyperuricaemia—Fludarabine—lymphatic system cancer	0.0296	0.0296	CcSEcCtD
Polythiazide—Blood uric acid increased—Fludarabine—lymphatic system cancer	0.028	0.028	CcSEcCtD
Polythiazide—Jaundice—Mechlorethamine—lymphatic system cancer	0.0231	0.0231	CcSEcCtD
Polythiazide—Agranulocytosis—Mechlorethamine—lymphatic system cancer	0.0221	0.0221	CcSEcCtD
Polythiazide—Hyperuricaemia—Vincristine—lymphatic system cancer	0.0181	0.0181	CcSEcCtD
Polythiazide—Hyperuricaemia—Mitoxantrone—lymphatic system cancer	0.0176	0.0176	CcSEcCtD
Polythiazide—Blood uric acid increased—Vincristine—lymphatic system cancer	0.0171	0.0171	CcSEcCtD
Polythiazide—Vertigo—Mechlorethamine—lymphatic system cancer	0.0167	0.0167	CcSEcCtD
Polythiazide—Blood uric acid increased—Mitoxantrone—lymphatic system cancer	0.0166	0.0166	CcSEcCtD
Polythiazide—Leukopenia—Mechlorethamine—lymphatic system cancer	0.0166	0.0166	CcSEcCtD
Polythiazide—Hyperglycaemia—Fludarabine—lymphatic system cancer	0.0156	0.0156	CcSEcCtD
Polythiazide—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.0148	0.0148	CcSEcCtD
Polythiazide—Anorexia—Mechlorethamine—lymphatic system cancer	0.0144	0.0144	CcSEcCtD
Polythiazide—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.0132	0.0132	CcSEcCtD
Polythiazide—Agitation—Teniposide—lymphatic system cancer	0.0126	0.0126	CcSEcCtD
Polythiazide—Leukopenia—Teniposide—lymphatic system cancer	0.0122	0.0122	CcSEcCtD
Polythiazide—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.0111	0.0111	CcSEcCtD
Polythiazide—Agitation—Fludarabine—lymphatic system cancer	0.011	0.011	CcSEcCtD
Polythiazide—Thrombocytopenia—Teniposide—lymphatic system cancer	0.0109	0.0109	CcSEcCtD
Polythiazide—Leukopenia—Fludarabine—lymphatic system cancer	0.0108	0.0108	CcSEcCtD
Polythiazide—Anorexia—Teniposide—lymphatic system cancer	0.0106	0.0106	CcSEcCtD
Polythiazide—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.0104	0.0104	CcSEcCtD
Polythiazide—Hyperglycaemia—Carmustine—lymphatic system cancer	0.00995	0.00995	CcSEcCtD
Polythiazide—Decreased appetite—Teniposide—lymphatic system cancer	0.0097	0.0097	CcSEcCtD
Polythiazide—Vomiting—Mechlorethamine—lymphatic system cancer	0.00962	0.00962	CcSEcCtD
Polythiazide—Photosensitivity reaction—Vincristine—lymphatic system cancer	0.00961	0.00961	CcSEcCtD
Polythiazide—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.0096	0.0096	CcSEcCtD
Polythiazide—Rash—Mechlorethamine—lymphatic system cancer	0.00954	0.00954	CcSEcCtD
Polythiazide—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00953	0.00953	CcSEcCtD
Polythiazide—Anorexia—Fludarabine—lymphatic system cancer	0.00935	0.00935	CcSEcCtD
Polythiazide—Hyperglycaemia—Mitoxantrone—lymphatic system cancer	0.00925	0.00925	CcSEcCtD
Polythiazide—Nausea—Mechlorethamine—lymphatic system cancer	0.00899	0.00899	CcSEcCtD
Polythiazide—Jaundice—Mitoxantrone—lymphatic system cancer	0.00892	0.00892	CcSEcCtD
Polythiazide—Urticaria—Teniposide—lymphatic system cancer	0.00886	0.00886	CcSEcCtD
Polythiazide—Paraesthesia—Fludarabine—lymphatic system cancer	0.0088	0.0088	CcSEcCtD
Polythiazide—Hyperuricaemia—Methotrexate—lymphatic system cancer	0.00878	0.00878	CcSEcCtD
Polythiazide—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00854	0.00854	CcSEcCtD
Polythiazide—Decreased appetite—Fludarabine—lymphatic system cancer	0.00852	0.00852	CcSEcCtD
Polythiazide—Constipation—Fludarabine—lymphatic system cancer	0.00838	0.00838	CcSEcCtD
Polythiazide—Vasculitis—Methotrexate—lymphatic system cancer	0.00835	0.00835	CcSEcCtD
Polythiazide—Blood uric acid increased—Methotrexate—lymphatic system cancer	0.0083	0.0083	CcSEcCtD
Polythiazide—Hypersensitivity—Teniposide—lymphatic system cancer	0.00822	0.00822	CcSEcCtD
Polythiazide—Asthenia—Teniposide—lymphatic system cancer	0.008	0.008	CcSEcCtD
Polythiazide—Leukopenia—Bleomycin—lymphatic system cancer	0.00788	0.00788	CcSEcCtD
Polythiazide—Aplastic anaemia—Methotrexate—lymphatic system cancer	0.00765	0.00765	CcSEcCtD
Polythiazide—Diarrhoea—Teniposide—lymphatic system cancer	0.00763	0.00763	CcSEcCtD
Polythiazide—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00722	0.00722	CcSEcCtD
Polythiazide—Vomiting—Teniposide—lymphatic system cancer	0.00709	0.00709	CcSEcCtD
Polythiazide—Agitation—Carmustine—lymphatic system cancer	0.00707	0.00707	CcSEcCtD
Polythiazide—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00704	0.00704	CcSEcCtD
Polythiazide—Asthenia—Fludarabine—lymphatic system cancer	0.00703	0.00703	CcSEcCtD
Polythiazide—Rash—Teniposide—lymphatic system cancer	0.00703	0.00703	CcSEcCtD
Polythiazide—Dermatitis—Teniposide—lymphatic system cancer	0.00703	0.00703	CcSEcCtD
Polythiazide—Headache—Teniposide—lymphatic system cancer	0.00699	0.00699	CcSEcCtD
Polythiazide—Leukopenia—Carmustine—lymphatic system cancer	0.00688	0.00688	CcSEcCtD
Polythiazide—Anorexia—Bleomycin—lymphatic system cancer	0.00685	0.00685	CcSEcCtD
Polythiazide—Agitation—Vincristine—lymphatic system cancer	0.00674	0.00674	CcSEcCtD
Polythiazide—Photosensitivity—Methotrexate—lymphatic system cancer	0.00673	0.00673	CcSEcCtD
Polythiazide—Diarrhoea—Fludarabine—lymphatic system cancer	0.00671	0.00671	CcSEcCtD
Polythiazide—Nausea—Teniposide—lymphatic system cancer	0.00663	0.00663	CcSEcCtD
Polythiazide—Vertigo—Vincristine—lymphatic system cancer	0.00659	0.00659	CcSEcCtD
Polythiazide—Leukopenia—Vincristine—lymphatic system cancer	0.00657	0.00657	CcSEcCtD
Polythiazide—Paraesthesia—Bleomycin—lymphatic system cancer	0.00645	0.00645	CcSEcCtD
Polythiazide—Leukopenia—Mitoxantrone—lymphatic system cancer	0.0064	0.0064	CcSEcCtD
Polythiazide—Decreased appetite—Bleomycin—lymphatic system cancer	0.00625	0.00625	CcSEcCtD
Polythiazide—Vomiting—Fludarabine—lymphatic system cancer	0.00623	0.00623	CcSEcCtD
Polythiazide—Rash—Fludarabine—lymphatic system cancer	0.00618	0.00618	CcSEcCtD
Polythiazide—Dermatitis—Fludarabine—lymphatic system cancer	0.00618	0.00618	CcSEcCtD
Polythiazide—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00614	0.00614	CcSEcCtD
Polythiazide—Headache—Fludarabine—lymphatic system cancer	0.00614	0.00614	CcSEcCtD
Polythiazide—Anorexia—Carmustine—lymphatic system cancer	0.00598	0.00598	CcSEcCtD
Polythiazide—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00586	0.00586	CcSEcCtD
Polythiazide—Nausea—Fludarabine—lymphatic system cancer	0.00582	0.00582	CcSEcCtD
Polythiazide—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00571	0.00571	CcSEcCtD
Polythiazide—Urticaria—Bleomycin—lymphatic system cancer	0.00571	0.00571	CcSEcCtD
Polythiazide—Anorexia—Vincristine—lymphatic system cancer	0.00571	0.00571	CcSEcCtD
Polythiazide—Paraesthesia—Carmustine—lymphatic system cancer	0.00563	0.00563	CcSEcCtD
Polythiazide—Anorexia—Mitoxantrone—lymphatic system cancer	0.00556	0.00556	CcSEcCtD
Polythiazide—Decreased appetite—Carmustine—lymphatic system cancer	0.00545	0.00545	CcSEcCtD
Polythiazide—Paraesthesia—Vincristine—lymphatic system cancer	0.00538	0.00538	CcSEcCtD
Polythiazide—Constipation—Carmustine—lymphatic system cancer	0.00537	0.00537	CcSEcCtD
Polythiazide—Hypersensitivity—Bleomycin—lymphatic system cancer	0.0053	0.0053	CcSEcCtD
Polythiazide—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00524	0.00524	CcSEcCtD
Polythiazide—Decreased appetite—Vincristine—lymphatic system cancer	0.00521	0.00521	CcSEcCtD
Polythiazide—Asthenia—Bleomycin—lymphatic system cancer	0.00516	0.00516	CcSEcCtD
Polythiazide—Constipation—Vincristine—lymphatic system cancer	0.00512	0.00512	CcSEcCtD
Polythiazide—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00507	0.00507	CcSEcCtD
Polythiazide—Pancreatitis—Methotrexate—lymphatic system cancer	0.00501	0.00501	CcSEcCtD
Polythiazide—Constipation—Mitoxantrone—lymphatic system cancer	0.00499	0.00499	CcSEcCtD
Polythiazide—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.00467	0.00467	CcSEcCtD
Polythiazide—Urticaria—Mitoxantrone—lymphatic system cancer	0.00463	0.00463	CcSEcCtD
Polythiazide—Hypersensitivity—Carmustine—lymphatic system cancer	0.00462	0.00462	CcSEcCtD
Polythiazide—Vomiting—Bleomycin—lymphatic system cancer	0.00457	0.00457	CcSEcCtD
Polythiazide—Rash—Bleomycin—lymphatic system cancer	0.00453	0.00453	CcSEcCtD
Polythiazide—Dermatitis—Bleomycin—lymphatic system cancer	0.00453	0.00453	CcSEcCtD
Polythiazide—Asthenia—Carmustine—lymphatic system cancer	0.0045	0.0045	CcSEcCtD
Polythiazide—Hypersensitivity—Vincristine—lymphatic system cancer	0.00441	0.00441	CcSEcCtD
Polythiazide—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.0043	0.0043	CcSEcCtD
Polythiazide—Asthenia—Vincristine—lymphatic system cancer	0.0043	0.0043	CcSEcCtD
Polythiazide—Diarrhoea—Carmustine—lymphatic system cancer	0.00429	0.00429	CcSEcCtD
Polythiazide—Nausea—Bleomycin—lymphatic system cancer	0.00427	0.00427	CcSEcCtD
Polythiazide—Agranulocytosis—Methotrexate—lymphatic system cancer	0.00425	0.00425	CcSEcCtD
Polythiazide—Asthenia—Mitoxantrone—lymphatic system cancer	0.00419	0.00419	CcSEcCtD
Polythiazide—Dizziness—Carmustine—lymphatic system cancer	0.00415	0.00415	CcSEcCtD
Polythiazide—Diarrhoea—Vincristine—lymphatic system cancer	0.0041	0.0041	CcSEcCtD
Polythiazide—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00399	0.00399	CcSEcCtD
Polythiazide—Vomiting—Carmustine—lymphatic system cancer	0.00399	0.00399	CcSEcCtD
Polythiazide—Dizziness—Vincristine—lymphatic system cancer	0.00396	0.00396	CcSEcCtD
Polythiazide—Rash—Carmustine—lymphatic system cancer	0.00396	0.00396	CcSEcCtD
Polythiazide—Dermatitis—Carmustine—lymphatic system cancer	0.00395	0.00395	CcSEcCtD
Polythiazide—Headache—Carmustine—lymphatic system cancer	0.00393	0.00393	CcSEcCtD
Polythiazide—Vomiting—Vincristine—lymphatic system cancer	0.00381	0.00381	CcSEcCtD
Polythiazide—Rash—Vincristine—lymphatic system cancer	0.00378	0.00378	CcSEcCtD
Polythiazide—Dermatitis—Vincristine—lymphatic system cancer	0.00377	0.00377	CcSEcCtD
Polythiazide—Headache—Vincristine—lymphatic system cancer	0.00375	0.00375	CcSEcCtD
Polythiazide—Nausea—Carmustine—lymphatic system cancer	0.00373	0.00373	CcSEcCtD
Polythiazide—Vomiting—Mitoxantrone—lymphatic system cancer	0.00371	0.00371	CcSEcCtD
Polythiazide—Rash—Mitoxantrone—lymphatic system cancer	0.00368	0.00368	CcSEcCtD
Polythiazide—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00367	0.00367	CcSEcCtD
Polythiazide—Headache—Mitoxantrone—lymphatic system cancer	0.00365	0.00365	CcSEcCtD
Polythiazide—Nausea—Vincristine—lymphatic system cancer	0.00356	0.00356	CcSEcCtD
Polythiazide—Nausea—Mitoxantrone—lymphatic system cancer	0.00346	0.00346	CcSEcCtD
Polythiazide—Vertigo—Methotrexate—lymphatic system cancer	0.0032	0.0032	CcSEcCtD
Polythiazide—Leukopenia—Methotrexate—lymphatic system cancer	0.00319	0.00319	CcSEcCtD
Polythiazide—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.00285	0.00285	CcSEcCtD
Polythiazide—Anorexia—Methotrexate—lymphatic system cancer	0.00277	0.00277	CcSEcCtD
Polythiazide—Paraesthesia—Methotrexate—lymphatic system cancer	0.00261	0.00261	CcSEcCtD
Polythiazide—Decreased appetite—Methotrexate—lymphatic system cancer	0.00253	0.00253	CcSEcCtD
Polythiazide—Urticaria—Methotrexate—lymphatic system cancer	0.00231	0.00231	CcSEcCtD
Polythiazide—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00214	0.00214	CcSEcCtD
Polythiazide—Asthenia—Methotrexate—lymphatic system cancer	0.00209	0.00209	CcSEcCtD
Polythiazide—Diarrhoea—Methotrexate—lymphatic system cancer	0.00199	0.00199	CcSEcCtD
Polythiazide—Dizziness—Methotrexate—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Polythiazide—Vomiting—Methotrexate—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Polythiazide—Rash—Methotrexate—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Polythiazide—Dermatitis—Methotrexate—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Polythiazide—Headache—Methotrexate—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Polythiazide—Nausea—Methotrexate—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
